Notably, the reduction in omentin is not limited to overweight individuals; patients with normal BMI and T2DM also display significantly lower omentin concentrations than healthy controls, indicating that the reduction is not solely attributable to obesity [4]. This evidence concerns the gene ITLN1 and type 2 diabetes mellitus.